If levels are too low, metabolic health issues are more likely to pop up, whereas higher levels are linked to improved glucose control, reduced appetite, and enhanced fat metabolism
For women navigating perimenopause or menopause, microdosing GLP-1 for menopause symptoms represents a potential tool for addressing metabolic changes during this transition
In June, a European medical safety committee noted that Wegovy and Ozempic have been linked in very rare cases to the eye condition, Reuters reported, which led Novo Nordisk to update its European labels for Wegovy and Ozempic to state that semaglutide, their active ingredient, may cause NAION in up to 1 in 10,000 patients
Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials Hypertension is strongly associated with increased body weight
Risk Matters When Considering Alternatives For patients at moderate to high risk of disease progression, standard immunosuppressive treatments remain essential
22 Pharmacists can play a pivotal role in addressing these challenges by proactively discussing medication access with patients and tailoring solutions based on individual factors such as drug type, indication, insurance coverage, and personal circumstances